Glenmark Pharmaceuticals Inc., USA is voluntarily recalling approximately 2,404 bottles of Indomethacin Extended-Release Capsules (75 mg). The recall was initiated because the medication failed dissolution testing, meaning it did not release the drug correctly during quality checks. The affected products include both 60-count and 90-count bottles of this prescription medication.
If the capsules do not dissolve correctly, the medication may not be absorbed by the body as intended. This could result in the patient receiving an incorrect dose, which may lead to the medication being less effective in treating pain and inflammation or potentially causing unexpected side effects.
You have 2 options:
Rx Only medication.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.